Rialto Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.6K Buy
1,457
+126
+9% +$3.35K 0.01% 347
2026
Q2
$32.1K Buy
1,331
+65
+5% +$1.7K 0.01% 366
2026
Q1
$35.6K Buy
1,266
+97
+8% +$2.58K 0.01% 318
2025
Q4
$29.1K Buy
1,169
+48
+4% +$1.21K 0.01% 324
2025
Q3
$28.6K Buy
1,121
+9
+0.8% +$222 0.01% 312
2025
Q2
$27K Buy
1,112
+82
+8% +$1.91K 0.01% 318
2025
Q1
$26.1K Buy
1,030
+37
+4% +$968 0.01% 316
2024
Q4
$26.3K Buy
+993
New +$26.9K 0.01% 311

Other funds holding PFE

Rialto Wealth Management's PFE Position: Q3 2026 in Review

Rialto Wealth Management increased its Pfizer (PFE) stake by 9.5% in Q3 2026, buying an estimated $3.35K and bringing the position to 1,457 shares worth $41.6K. The position accounts for 0.01% of the portfolio, ranked #347.

Rialto Wealth Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Rialto Wealth Management held 1,457 shares of Pfizer worth $41.6K as of Q3 2026.
  • Rialto Wealth Management bought 126 Pfizer shares in Q3 2026, an estimated $3.35K.
  • Pfizer made up 0.01% of Rialto Wealth Management's portfolio in Q3 2026, its #347 holding.
  • Rialto Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.